869749-04-2

Hydrogen, compd. with krypton (1:1)

1H-Indole-2-carboxylic acid, 3-iodo-1-(phenylsulfonyl)-, ethyl ester

Phenol, 2-amino-3-(ethylamino)-

Ethanamine, N-methyl-N-nitro-2-(oxiranylmethoxy)-

5H-1,3-Dioxolo[4,5-g][2]benzopyran-8-methanol, 7,8-dihydro-7-phenyl-,cis-

Acetaldehyde, bis(phenylthio)-

1,5-Hexanediol, 2-ethyl-

2-Butenedioic acid, 2-(methylamino)-, dimethyl ester, (E)-

1H-Benzimidazol-4-ol,1-methyl-2-(1-methylethyl)-

5-(4-amino-2-methoxyphenoxy)-3,3-diethyl-2,2-dihydroxy-1-phenylpentan-1-one

FURO[2,3-B]PYRIDINE-2-METHANAMINE

Benzofuran, 7-(chloromethyl)-3-phenyl-

1H-2-Benzopyran-4-carboxylic acid,3,4-dihydro-6,7-dimethoxy-3-phenyl-, methyl ester, trans-

S-hexyl acetylcarbamothioate

1H-Isoindole-1,3(2H)-dione,2-(4-oxo-1,2,3,5-tetraphenyl-6-azabicyclo[3.1.0]hex-2-en-6-yl)-

2H-Cyclopenta[b]furan-2-one, 4,5,6,6a-tetrahydro-3-methyl-

Sodium, (1,2,3-triphenyl-2-propenyl)-

diazepam binding inhibitor (39-75)

1,2-diiodo-4-nitrobenzene

1H-2-Benzopyran-4-methanol, 3,4-dihydro-6,7-dimethoxy-3-phenyl-,trans-

O-ANISALAZINE

1H-Indole-2-propanoic acid

5H-Pyrrolo[1,2-b][1,2,4]triazol-7-ol,6,7-dihydro-

Hydrazinecarboxylic acid, 2-(phenylsulfonyl)-, dodecyl ester

Pentanoic acid, 5,5'-dioxybis[5-oxo-,bis[2-[(1,1-dimethylethyl)dioxy]ethyl] ester

4-(hexyloxy)-3-methoxyaniline

4,4'-Bipyridinium, 1-[2-(2-hydroxyethoxy)ethyl]-, iodide

Ethanone, 2-amino-1-(6-methoxy-2-naphthalenyl)-, hydrochloride

1,4-Benzodioxin-2(3H)-one,7-[[(4-chlorophenyl)amino]methyl]-3,3-dimethyl-

Ethane, 1,1,1-trichloro-2,2-difluoro-2-isocyanato-

4-Amino-3-[[4-[5-[(2,4-diaminophenyl)azo]-1H-benzimidazol-2-yl]phenyl]azo]-5-hydroxy-6-(phenylazo)-2,7-naphthalenedisulfonic acid

3-Ethyl-1,2,3,4,5,6,8,9,9a,14-decahydro-9a-hydroxy-3,7-methanoazocino[1,2:1,2]pyrrolo[2,3-b]indol-7-ium

3-Pyridinecarboxamide, 1,4-dihydro-N-(1-phenylethyl)-1-propyl-, (S)-

Hydrazinecarboxylic acid, 2-(ethylsulfonyl)-, propyl ester

1H-Pyrrole-2-carboxaldehyde,3,5-dimethyl-4-(5,9,13-trimethyl-1-oxo-4,8,12-tetradecatrienyl)-

3,7-Nonanedione,1,5-dihydroxy-2,4-bis(hydroxymethyl)-1-[(2R,3R)-2-methyl-3-[(1S,2Z)-1-methyl-2-butenyl]oxiranyl]-, (1S,2R,4R,5S)-

1H-Pyrazole-3-carboxylic acid, 2,5-dihydro-2-methyl-5-oxo-

869749-04-2 msds

CAS No 869749-04-2 supplier

CASNo 869749-04-2 distributor

CAS # 869749-04-2 manufacturer

CAS Number 869749-04-2 safety

CAS RN 869749-04-2 wholesale

2026-10-13 Hydrogen, compd. with krypton (1:1),CAS No.869749-04-2,Formula:H2·Kr. Find Related Products for Bulk Production or Scientific Research